Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.40 |
| ▸ | NPY1R | P25929 | 7/20 | 0.40 |
| ▸ | NPY2R | P49146 | 5/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.40 |
| ▸ | ENPEP | Q07075 | 7/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15011349 | 1.00 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL9614927 | 1.00 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30111320 | 0.97 | NPY4R (0.43) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31265334 | 0.95 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30484000 | 0.94 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31318675 | 0.94 | ENPEP (0.47) | ENPEP | |
| SCHEMBL19554383 | 0.94 | NPY4R (0.39) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31410877 | 0.93 | ENPEP (0.40) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| SCHEMBL31206444 | 0.93 | ENPEP (0.47) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| Trifluoroacetic Acid SCHEMBL7445661 | 0.93 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101184510-A | Methods of treating various disorders by administering sustained release L-arginine | ENOS PHARMACEUTICALS INC (US) | 2008-05-21 | — | — | CN | disclosed |